Literature DB >> 13559919

Industrial anthrax.

P S BRACHMAN, F R FEKETY.   

Abstract

Entities:  

Keywords:  ANTHRAX; OCCUPATIONAL DISEASES

Mesh：

Year:  1958        PMID： 13559919     DOI： 10.1111/j.1749-6632.1958.tb35413.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  THE RELATION OF SURFACE CONTAMINATION TO THE TRANSMISSION OF DISEASE.

Authors:  W R SANBORN
Journal:  Am J Public Health Nations Health       Date:  1963-08

2.  Discussion.

Authors:  H N Glassman
Journal:  Bacteriol Rev       Date:  1966-09

3.  Field Evaluation of a Human Anthrax Vaccine.

Authors:  P S Brachman; H Gold; S A Plotkin; F R Fekety; M Werrin; N R Ingraham
Journal:  Am J Public Health Nations Health       Date:  1962-04

4.  Industrial inhalation Anthrax.

Authors:  P S Brachman; A F Kaufman; F G Dalldorf
Journal:  Bacteriol Rev       Date:  1966-09

5.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06

Review 6.  Pathways to zoonotic spillover.

Authors:  Raina K Plowright; Colin R Parrish; Hamish McCallum; Peter J Hudson; Albert I Ko; Andrea L Graham; James O Lloyd-Smith
Journal:  Nat Rev Microbiol       Date:  2017-05-30       Impact factor: 60.633

7.  Serological evidence for human exposure to Bacillus cereus biovar anthracis in the villages around Taï National Park, Côte d'Ivoire.

Authors:  Susann Dupke; Grit Schubert; Félicité Beudjé; Anne Barduhn; Maude Pauly; Emmanuel Couacy-Hymann; Roland Grunow; Chantal Akoua-Koffi; Fabian H Leendertz; Silke R Klee
Journal:  PLoS Negl Trop Dis       Date:  2020-05-14

8.  Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001.

Authors:  Michael E Bales; Andrew L Dannenberg; Philip S Brachman; Arnold F Kaufmann; Peter C Klatsky; David A Ashford
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.